Excipient Granules And Ingredients Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-01-2025
- Paid Up Capital ₹ 0.10 M
as on 14-01-2025
- Company Age 1 Year 22 Days
- Last Filing with ROC 31 Mar 2024
About Excipient Granules And Ingredients
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Umang Budhraja and Nidhi Budhraja serve as directors at the Company.
- CIN/LLPIN
U46691MH2024PTC416617
- Company No.
416617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2024
- Date of AGM
23 Nov 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Excipient Granules And Ingredients?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Budhraja  | Director | 03-Jan-2024 | Current |
| Nidhi Budhraja | Director | 03-Jan-2024 | Current |
Financial Performance of Excipient Granules And Ingredients.
Enhance accessibility to Excipient Granules And Ingredients's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Excipient Granules And Ingredients?
Unlock access to Excipient Granules And Ingredients's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Umang Global Group Private LimitedActive 4 years 10 monthsUmang Budhraja and Nidhi Budhraja are mutual person
Labultima Process Technologies Private LimitedActive 8 years 11 monthsUmang Budhraja is a mutual person
Umang Particle Science Private LimitedActive 3 years 9 monthsUmang Budhraja and Nidhi Budhraja are mutual person
- Umang Encapsulation Solutions Private LimitedActive 3 years 9 months
Umang Budhraja and Nidhi Budhraja are mutual person
- Umang Consumer Products Private LimitedActive 1 year 30 days
Umang Budhraja and Nidhi Budhraja are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Excipient Granules And Ingredients?
Unlock and access historical data on people associated with Excipient Granules And Ingredients, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excipient Granules And Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excipient Granules And Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.